Atoms for Peace Atoms for Peace ABSTRACTS International Conference on Clinical PET and Molecular Nuclear Medicine (ipet 2011) 8–11 November 2011 Vienna, Austria IAEA CN-185 International Conference on Clinical PET and Molecular Nuclear Medicine (IPET 2011) Vienna, Austria 8–11 November 2011 BOOK OF ABSTRACTS IAEA-CN-185 CONTENTS CLINICAL PET ONCOLOGY IAEA-CN-185/104 ............................................................................................................ 2 Feasibility of biopsy guided by FDG-PET/CT in oncological patients J.J. Cerci, C.C. Pereira Neto, J.V. Vitola IAEA-CN-185/105 ............................................................................................................ 3 Importance of 18F-FDG PET/CT imaging in patients with lymphoma and residual CT mass after treatment D. Sobic-Saranovic, V. Artiko, M. Todorovic-Tirnanic, V. Obradovic IAEA-CN-185/106 ............................................................................................................ 4 PET/CT in diagnosis of metastases and recurrences of colorectal carcinomas V. Artiko, D. Sobic-Saranovic, N. Petrovic, V. Obradovic IAEA-CN-185/107 ............................................................................................................ 5 Pitfalls encountered in 1500 hybrid PET/CT studies V.E. Soroa, J. Arashiro, M.M. Volpacchio, G. Rank, C. Giannone IAEA-CN-185/113 ............................................................................................................ 8 Results of initial FDG PET/CT staging in recently diagnosed breast cancer patients S. Ozguven, F. Dede, T. Ones, B. Gulluoglu, S. Inanir, T.Y. Erdil, H.T. Turoglu IAEA-CN-185/114 ............................................................................................................ 9 Morpho-metabolical changes at the operation site in recently mastectomized patients: Impact of staging FDG PET/CT S. Ozguven, F. Dede, T. Ones, B. Gulluoglu, S. Inanir, T.Y. Erdil, H.T. Turoglu IAEA-CN-185/115 .......................................................................................................... 10 Synchronous metastases in recently diagnosed breast cancer: Role of staging FDG PET/CT S. Ozguven, F. Dede, T. Ones, B. Gulluoglu, S. Inanir, T.Y. Erdil, H.T. Turoglu IAEA-CN-185/117 .......................................................................................................... 11 The value of FDG-PET/CT imaging in dermatomyositis as a paraneoplastic syndrome in malignancy suspicion M. Aras, T. Ones, F. Dede, F. Novruzov, S.S.C. Omercikoglu, S.Ozguven, S. Gungor, S. Inanir, T.Y. Erdil, H.T. Turoglu IAEA-CN-185/121 .......................................................................................................... 13 Radiological response evaluation of oncolytic virus treatment in patients with advanced cancer A. Koski, K. Kairemo, M. Oksanen, A. Koskela, K. Partanen, A. Hemminki IAEA-CN-185/123 .......................................................................................................... 14 FDG PET in nephrourinary cancer: Our experience in 60 cases M.J. Jofré, T. Massardo, M.P. Sierralta, J. Canessa, G. Castro, I. Berrocal, R. Valdebenito IAEA-CN-185/125 .......................................................................................................... 16 Significant impact of mid treatment 18-F FDG PET-CT as a prognostic indicator in the management and follow-up of metastatic breast cancer P.S. Choudhury, M. Gupta, A. Chaturvedi, A. Dogra IAEA-CN-185/126 .......................................................................................................... 17 Usefulness of FDG-PET in the evaluation of sarcomas from diverse origin J. Canessa, T. Massardo, G. Castro, M.J. Jofré, M.P. Sierralta, I. Berrocal, I. Gallegos, R. Valdebenito, A. Quenaya iv IAEA-CN-185/143 .......................................................................................................... 19 Evaluation of somatostatin receptors in prostate cancer lesions with Ga-68- DOTATATE PET-CT O. Alonso, J.P. Gambini, G. Lago, J. Gaudiano, A. Paolino, M. González, H. Engler IAEA-CN-185/150 .......................................................................................................... 20 Clinical study of 18F-FDG PET/CT in diagnosis and management of lung cancer Y.P. Dang, Q. Wang IAEA-CN-185/154 .......................................................................................................... 21 Evaluation of 18F-FDOPA PET-CT and its comparison with 99mTc- GHA SPECT/CT in detection of recurrence in patients with high grade primary glioma S. Karunanithi, C.S. Bal, A. Malhotra, G.P. Bandopadhyaya IAEA-CN-185/156 .......................................................................................................... 22 Role of 18F-FDG PET/CT in response evaluation of metastatic gastrointestinal stromal tumours to Imatinib Mesylate: Indian experience S. Jeph, R. Kumar, C.S. Bal, A. Malhotra IAEA-CN-185/158 .......................................................................................................... 23 Application of PET/CT simulation in radiation planning at the nuclear medicine and oncology centre, Bach Mai Hospital, HANOI, Vietnam M.T. Khoa, V.H. Khiem, P.C. Phuong, P.V. Thai, T.H. Binh, N.T. Chuong, N.T. Trang et al. IAEA-CN-185/161 .......................................................................................................... 24 Clinical utility of FDG PET/CT in patients with lymphoma J. Mihailovic, S. Goldsmith, R. Killeen, A. Abi Ghanem IAEA-CN-185/164 .......................................................................................................... 25 Reliability of 18F-FDG PET/CT after 2 cycles of chemotherapy for prognosis prediction in patients with Non-Hodgkin lymphoma L. Henzlová, M. Mysliveček, P. Koranda, T. Papajík, E. Buriánková, Z. Kapitá ňová IAEA-CN-185/165 .......................................................................................................... 26 18F-FDG PET/CT under TSH stimulation in patients with differentiated thyroid carcinoma H. Crhakova, P. Koranda, L. Henzlova, M. Dockal, M. Myslivecek IAEA-CN-185/166 .......................................................................................................... 27 Identification of cancer metastases using the combination of PET and viral vectors P. Brader, Z. Gil, Y. Fong, T. Helbich, H. Hricak, C. Herold IAEA-CN-185/168 .......................................................................................................... 29 PET/CT examinations with 68Ga -DOATATE in neuroendocrine tumours - Characterization of physiological uptake in organs in diagnosis of primary tumours J. Kunikowska, L. Krolicki, D. Pawlak, I. Zerizer, L. Grabowska, R. Mikołajczak IAEA-CN-185/172 .......................................................................................................... 31 PET / CT with 11C-acetate in prostate cancer: Appropriate diagnostic tool F. Martínez-Preciado, M. Patiño-Zarco, E. Estrada-Lobato, O.F. García-Pérez, I. Soldevilla-Gallardo IAEA-CN-185/180 .......................................................................................................... 32 Utility of 18 F-FDG PET-CT in the evaluation of orbital tumours M.A. Maltez Cruz v IAEA-CN-185/187 .......................................................................................................... 33 Diagnostic and prognostic value of 18F-FDG PET/CT on cancer of unknown primary S. Carmona, J. Santos, L. Oliveira, P. Colarinha, A.L. Bastos, A.I. Santos IAEA-CN-185/188 .......................................................................................................... 35 Intra-abdominal neoplasms – MRI versus 18F-FDG-PET/CT J. Santos, S. Carmona, C. Bagulho, L. Oliveira, P. Colarinha, A.L. Bastos, A.I. Santos IAEA-CN-185/190 .......................................................................................................... 36 Clinical characteristics and 18F-FDG PET/CT imaging in differentiated thyroid carcinoma patients with negative 131I whole-body scan and elevated serum thyroglobulin L.N. Ha, L.M. Ha, L.D. Hung, N.T. Huong IAEA-CN-185/191 .......................................................................................................... 38 PET/CT imaging with 68Ga-DOTATATE in the evaluation of neuroendocrine tumours (NET): Our leading experience in Chile H. Amaral, M. Cecilia Gil, H. Lavados, F. Redondo, R. Pruzzo, I. Coudeu, S. Astudillo, R. Galaz, C. Chamorro, L. Cantuarias IAEA-CN-185/192 .......................................................................................................... 40 Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in thyroid carcinoma patients with negative diagnostic total body scan in Thailand: A decision analysis K. Benjapa, N. Cherdchai, P. Pawana, T. Pongpija, T. Napaporn IAEA-CN-185/195 .......................................................................................................... 41 18FDG PET-CT role in management of dedifferentiated thyroid cancer P. Kundu, Snehlata, A. Malhotra, C.S. Bal IAEA-CN-185/197 .......................................................................................................... 42 Role of 18F-FDG PET-CT in medullary thyroid carcinoma and correlation with serum calcitonin C.B. Khangembam, C.S. Bal, R. Kumar, A. Malhotra IAEA-CN-185/199 .......................................................................................................... 43 Early assessment for suspected